Stocks and Investing Stocks and Investing
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021
Thu, March 25, 2021
Wed, March 24, 2021
Tue, March 23, 2021

Matthew Harrison Maintained (ADCT) at Buy with Decreased Target to $55 on, Mar 23rd, 2021


Published on 2024-10-27 16:01:12 - WOPRAI
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $56 to $55 on, Mar 23rd, 2021.

Matthew has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Konstantinos Aprilakis of "Stifel" Initiated at Hold and Held Target at $42 on, Thursday, December 3rd, 2020


This is the rating of the analyst that currently disagrees with Matthew


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $48 on, Friday, March 19th, 2021